To assess whether orange peel fermentation has the effect of reducing body fat in adults
This is a double-blind and randomized study. Subjects are informed to consume the samples every day for 2 months. The clinical diagnosis item of overweight or fatty liver is evaluated by the doctor. The questionnaires are collected at every visit of the trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
124
consume 1 sachet per day for 2 months
consume 1 sachet per day for 2 months
National Taiwan University Hospital
Taipei, Taiwan, Taiwan
RECRUITINGThe change of body fat mass
The body fat mass (kg) was assessed by InBody770
Time frame: Weeks 0, 4 and 8
The change of Triglyceride
Venous blood was sampled to measure concentrations of Triglyceride
Time frame: Weeks 0, 4 and 8
The change of Total cholestrol
Venous blood was sampled to measure concentrations of Total cholestrol
Time frame: Weeks 0, 4 and 8
The change of HDL-cholestrol
Venous blood was sampled to measure concentrations of HDL-cholestrol
Time frame: Weeks 0, 4 and 8
The change of LDL-cholestrol
Venous blood was sampled to measure concentrations of LDL-cholestrol
Time frame: Weeks 0, 4 and 8
The change of body mass index (BMI)
BMI is a measurement of a person's leanness or corpulence based on their height and weight, and is intended to quantify tissue mass.The body mass index (BMI, kg/m\^2) and body mass (kg) were assessed by InBody770.
Time frame: Weeks 0, 4 and 8
The change of body fat percentage
The body fat percentage (%) was assessed by InBody770.
Time frame: Weeks 0, 4 and 8
The change of visceral fat
The visceral fat (10 cm\^2) was assessed by InBody770.
Time frame: Weeks 0, 4 and 8
The change of fasting glycemia
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Venous blood was sampled to measure concentrations of fasting glycemia
Time frame: Weeks 0, 4 and 8
The change of aspartate aminotransferase
Venous blood was sampled to measure concentrations of aspartate aminotransferase
Time frame: Weeks 0, 4 and 8
The change of alanine aminotransferase
Venous blood was sampled to measure concentrations of alanine aminotransferase
Time frame: Weeks 0, 4 and 8
The change of albumin
Venous blood was sampled to measure concentrations of creatine
Time frame: Weeks 0, 4 and 8
The change of creatine
Venous blood was sampled to measure concentrations of creatine
Time frame: Weeks 0, 4 and 8
The change of uric acid
Venous blood was sampled to measure concentrations of uric acid
Time frame: Weeks 0, 4 and 8
The change of white blood cell
Venous blood was sampled to measure concentrations of white blood cell
Time frame: Weeks 0, 4 and 8